18:1 PEG350 PE

Product Specifications

Bioactivity

18:1 PEG350 PE is a PEG lipid functional end group used in synthesizing liposomes (LPs) that is designed for the creation of conjugated polymer nanoparticles. Liposome nanoparticles (LNPs) can couple with other biomolecules through biotin modifications and carboxyl terminals. Functionalized nanoparticles are employed for targeted labeling of specific cell proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles can bind to biotinylated antibodies on cell surface receptors, facilitating fluorescence-based imaging and sensing applications.

Molecular Formula

(C2H4O) nC43H80NO10P.NH3

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

GTR15376329 1 Vial

Lentiviral human CNOT11 sgRNA gene knockout kit - Lentiviral human CNOT11 sgRNA gene knockout kit (25)

View Details

ARP90843_P050 100 µL

Apobec2 Antibody Middle region

View Details

RG-A261173-01 10 mg

(Z) -5-Imino-6- (4- (2-Phenoxyethoxy) Benzylidene) -2-Phenyl-5,6-Dihydro-7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidin-7-One

View Details

RG-A261173-02 25 mg

(Z) -5-Imino-6- (4- (2-Phenoxyethoxy) Benzylidene) -2-Phenyl-5,6-Dihydro-7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidin-7-One

View Details

RG-A261173-03 50 mg

(Z) -5-Imino-6- (4- (2-Phenoxyethoxy) Benzylidene) -2-Phenyl-5,6-Dihydro-7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidin-7-One

View Details

RG-A261173-04 100 mg

(Z) -5-Imino-6- (4- (2-Phenoxyethoxy) Benzylidene) -2-Phenyl-5,6-Dihydro-7H-[1,3,4]Thiadiazolo[3,2-A]Pyrimidin-7-One

View Details